Suppr超能文献

加纳因肝硬化和肝细胞癌导致的死亡率负担;危险因素的流行情况以及住院期间生存不良的预测因素。

Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival.

机构信息

Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.

Department of Internal Medicine, Cape Coast Teaching Hospital, Cape Coast, Ghana.

出版信息

PLoS One. 2022 Sep 13;17(9):e0274544. doi: 10.1371/journal.pone.0274544. eCollection 2022.

Abstract

Liver-related diseases, including liver cirrhosis and hepatocellular carcinoma (HCC), are significant causes of mortality globally. Specific causes and predictors of liver-related mortality in low resource settings require assessment to help inform clinical decision making and develop strategies for improved survival. The objectives of this study were to determine the proportion of liver-related deaths associated with liver cirrhosis, HCC, and their known risk factors, and secondly to determine predictors of in-hospital mortality among cirrhosis and HCC patients in Ghana. We first performed a cross-sectional review of death register entries from 11 referral hospitals in Ghana to determine the proportion of liver-related deaths and the proportion of risk factors associated with these deaths. Secondly, we conducted a retrospective cohort review of 172 in-patient liver cirrhosis and HCC cases admitted to a tertiary referral centre and determined predictors of in-hospital mortality using binary logistic regression and Kaplan-Meier survival analysis. In total, 8.8% of deaths in Ghanaian adults were due to liver-related causes. The proportion of liver-related deaths attributed to HBV infection was 48.8% (95% CI: 45.95-51.76), HCV infection was 7.0% (95% CI: 5.58-8.45), HBV-HCV co-infection 0.5% (95% CI: 0.1-0.9) and alcohol was 10.0% (95% CI: 8.30-11.67). Of 172 cases of HCC and liver cirrhosis, the in-patient mortality rate was 54.1%. Predictors of in-patient mortality in cirrhotic patients were increasing WBC (OR = 1.14 95% CI: 1.00-1.30) and the revised model for end-stage liver disease with sodium (MELD-Na) score (OR = 1.24 95% CI: 1.01-1.54). For HCC patients, female sex (OR = 3.74 95% CI: 1.09-12.81) and hepatic encephalopathy (grade 1) were associated with higher mortality (OR = 5.66 95% CI: 1.10-29.2). In conclusion, HBV is linked to a high proportion of HCC-related deaths in Ghana, with high in-hospital mortality rates that require targeted policies to improve survival.

摘要

肝脏相关疾病,包括肝硬化和肝细胞癌(HCC),是全球范围内导致死亡的重要原因。在资源匮乏的环境中,需要评估肝脏相关死亡的具体原因和预测因素,以帮助为临床决策提供信息并制定提高生存率的策略。本研究的目的是确定与肝硬化、HCC 及其已知危险因素相关的肝脏相关死亡比例,其次是确定加纳肝硬化和 HCC 患者住院死亡率的预测因素。我们首先对加纳 11 家转诊医院的死亡登记条目进行了横断面回顾,以确定肝脏相关死亡的比例以及与这些死亡相关的危险因素的比例。其次,我们对一家三级转诊中心收治的 172 例住院肝硬化和 HCC 病例进行了回顾性队列研究,并使用二项逻辑回归和 Kaplan-Meier 生存分析确定了住院死亡率的预测因素。在加纳成年人中,8.8%的死亡是由肝脏相关原因引起的。归因于乙型肝炎病毒(HBV)感染的肝脏相关死亡比例为 48.8%(95%可信区间:45.95-51.76),丙型肝炎病毒(HCV)感染为 7.0%(95%可信区间:5.58-8.45),HBV-HCV 合并感染为 0.5%(95%可信区间:0.1-0.9),酒精为 10.0%(95%可信区间:8.30-11.67)。在 172 例 HCC 和肝硬化病例中,住院死亡率为 54.1%。肝硬化患者住院死亡率的预测因素包括白细胞计数(WBC)增加(OR=1.14,95%可信区间:1.00-1.30)和终末期肝病模型钠(MELD-Na)评分(OR=1.24,95%可信区间:1.01-1.54)。对于 HCC 患者,女性(OR=3.74,95%可信区间:1.09-12.81)和肝性脑病(1 级)与更高的死亡率相关(OR=5.66,95%可信区间:1.10-29.2)。总之,HBV 与加纳 HCC 相关死亡的高比例相关,住院死亡率高,需要制定有针对性的政策来提高生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9469955/43623061b5ad/pone.0274544.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验